Semax is a drug produced and prescribed mostly in Russia and Ukraine for a broad range of disorders but predominantly for its purported nootropic neuroprotective and neurorestorative properties. Semax is a heptapeptide synthetic analogue of an ACTH (4-10) fragment of corticotropin of the following structure: Met-Glu-His-Phe-Pro-Gly-Pro. Based on one of the endogenous neuropeptides regulating the functions of the central nervous system. The compound has not been evaluated by the FDA.
This page contains content from the copyrighted Wikipedia article "Semax"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.